What is galcanezumab-gnlm?

Category: Prescription Drugs

Most popular types: Emgality

false

Galcanezumab is a medication that can be used for the prevention of migraine.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Migraine 26 5
Migraine headaches 5 1
Migraine with aura 4 0
Prevent migraine 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 1
Mild 4
None 1

Commonly reported side effects and conditions associated with galcanezumab-gnlm

Side effect Patients Percentage
Injection site itching 1
Muscle pain 1
Short term memory problems 1
Skin pain 1
Swelling in lower extremities 1

Dosages

Based on patients currently taking galcanezumab-gnlm

Dosage Patients Percentage
120 mg monthly 4
unspecified 1

Why patients stopped taking galcanezumab-gnlm

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 3
Side effects too severe 1
See all 3 patients who've stopped taking galcanezumab-gnlm

Duration

Currently taking galcanezumab-gnlm

Duration Patients Percentage
1 - 6 months 1
1 - 2 years 2
2 - 5 years 3

Stopped taking galcanezumab-gnlm

Duration Patients Percentage
1 - 6 months 1
6 months - 1 year 1
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 7
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 3
Not at all hard to take 3
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 4
Not specified 3

What people switch to and from

Patients started taking galcanezumab-gnlm after stopping:

Treatment Patients Percentage
Erenumab (Aimovig) 4
Amitriptyline (Elavil) 1
Botulinum Toxin Type A (Botox) 1
Propranolol (Inderal) 1

Patients stopped taking galcanezumab-gnlm and switched to:

Treatment Patients Percentage
Fremanezumab (Ajovy) 2
Acetaminophen-butalbital-caffeine-codeine (Fioricet with Codeine) 1
Last updated:
There are no evaluations for galcanezumab-gnlm.